A new study examined patient experiences with long-COVID and identified four distinct groupings encompassin...
Other content in this Stream
Learn about the latest findings and treatments for post-COVID syndrome from Providence.
In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.
A data analysis initiative supported by Providence CORE could significantly influence behavioral health policy and response strategies in Portland, Oregon, and statewide.
Patients with liver cancer have a new treatment option, thanks to a revolutionary procedure being offered at Providence and Providence Swedish hospitals.
Research by Providence CORE offers insights to help healthcare organizations partner with patients to improve outcomes through genetic testing.
New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy
A study led by Providence researcher Katherine Tuttle, MD, FACP, of Spokane, Washington is in the news thanks to findings around a promising new treatment for kidney disease.
New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.
Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.
Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.
In a new interview, Providence CORE researcher Monique Gill discusses CORE’s research on the links between healthcare experiences and engagement with mammography.
Learn how Providence is bringing top-tier research to its rural health programs so patients have access to lifesaving therapies – wherever they are.
A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.
Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.
SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.
A new study examined patient experiences with long-COVID and identified four distinct groupings encompassing the wide-ranging experiences of long COVID patients.
Swedish Edmonds Dr. Kelly Paulson wins the first-ever Jeff Ward Award for excellence in care.
Jaundice was the first symptom of what a CT scan would confirm was pancreatic cancer. A small tumor blocked one of Sharon Stefan’s bile ducts, causing the telltale symptom that, for many, doesn’t appe
Providence study seeks to help practitioners better identify and care for patients by providing a more comprehensive understanding of how long COVID presents and the patient experience of this disease
Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.